Chapter 19

Question 1

Which of the following is FALSE about pharmacoeconomics?

A. Evaluates the cost-effectiveness of pharmaceutical products or services by comparing the economic resources (inputs) to the amount of pharmacy products or services provided (outputs).
B. Prior to pharmacoeconomics used as a term, the focus of economic evaluation to pharmacy was mainly pharmacy services instead of pharmaceuticals.
C. Evaluations have been used by decision makers to optimize the use of prescription therapy.
D. Describe a complication of methods that evaluate the economic, clinical, and humanistic outcomes of pharmaceutical products and services.

Answer 1

A. Evaluates the cost-effectiveness of pharmaceutical products or services by comparing the economic resources (inputs) to the amount of pharmacy products or services provided (outputs).

Question 2

If you wanted to compare the costs and consequences of two or more alternatives and determine which one can achieve the best outcome at lowest cost, which pharmacoeconomic methodology would you use?

A. Cost- Minimization Analysis (CMA)
B. Cost-Benefit Analysis (CBA)
C. Cost-Utility Analysis (CUA)
D. Cost-Effectiveness Analysis (CEA)

Answer 2

D. Cost-Effectiveness Analysis (CEA)

Question 3

A patient needing less intervention and treatment due to a pharmaceutical drug is an example of a(n)..?

A. Outcome
B. Output
C. Input
D. Pharmacoeconomic Analysis

Answer 3

A. Outcome

Question 4

Which of the following terms is defined by the following question: “Does the product work?”

A. Efficiency
B. Effectiveness
C. Efficacy
D. Effuses

Answer 4

C. Efficacy

Question 5

Which of the following would be considered a clinical end point for a patient with hypertension?

A. Increased morbidity
B. Achieving a normal blood pressure reading.
C. A cure (health is restored)
D. Death

Answer 5

B. Achieving a normal blood pressure reading.